brimapitide   Click here for help

GtoPdb Ligand ID: 9101

Synonyms: AM-111 | D-JNKI-1 | XG-102
Immunopharmacology Ligand
Comment: Brimapitide is a highly selective, non-competitive, long-acting inhibitor of c-jun N-terminal kinase (JNK). The peptide is an investigational drug for the intratympanic (i.t.) treatment of acute sensorineural hearing loss (ASNHL). Structurally the peptide consists of 20 amino acids from C-Jun-amino-terminal kinase-interacting protein 1 (JIP-1) fused to a carrier peptide derived from HIV-TAT48-57 (TAT) peptide PPRRRQRRKKRG. The peptide is constructed in a D-retro-inverso configuration to render it protease resistant. The TAT peptide mediates cell permeability. The sequence is claimed in patent US8080517 (SEQ ID NO: 11, D-JNKI1) [2]. The research codes XG-102 and AM-111 seem to be applied to this investigational agent.
Click here for help
Classification Click here for help
Compound class Peptide or derivative
International Nonproprietary Names Click here for help
INN number INN
10207 brimapitide
Synonyms Click here for help
AM-111 | D-JNKI-1 | XG-102
Database Links Click here for help
GtoPdb PubChem SID 315661186
Search PubMed clinical trials brimapitide
Search PubMed titles brimapitide
Search PubMed titles/abstracts brimapitide